NIH awards Vixar a Phase I SBIR (Small Business Innovation Research) contract to develop a tunable VCSEL

摘要

The National Institutes of Health's National Cancer Institute has awarded Vixar a Small Business Innovation Research (SBIR) Phase I contract to demonstrate the feasibility of a wavelength-tunable VCSEL achieving a tuning range of 35nm. Working with Vixar on this effort is the Beckman Laser Institute at the University of California, Irvine.This project will develop a swept near-infrared light source that enables a portable hyperspectral tomographic functional optical imager. While such a device has many applications within endogenous NIR spectroscopy and imaging, or molecular imaging spectroscopy, Vixar will focus on the application of the light source within an instrument designed for detecting, characterizing and therapeutic monitoring of breast cancer. The optical source is expected to enable improved image signal to noise, contrast, and imaging depth.